Evaluation of survival in Japanese stage IV melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cells.
Nakai
Noriaki
N
Katoh
Norito
N
Kitagawa
Tomoko
T
Ueda
Eiichiro
E
Takenaka
Hideya
H
Kishimoto
Saburo
S
D000328:Adult; D000368:Aged; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003713:Dendritic Cells; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate
D019496:Cancer Vaccines